-
1.
公开(公告)号:US09320592B2
公开(公告)日:2016-04-26
申请号:US13844577
申请日:2013-03-15
Applicant: Covidien LP
Inventor: John Wainwright , Todd Mendelson , Kurt Haggstrom , Masoud Molaei , Victoria Schuman , Min-Shyan Sheu
CPC classification number: A61F2/07 , A61F2/90 , A61F2002/072 , A61F2002/823 , A61F2250/0067
Abstract: Coating methods and related devices are provided. Such devices can include stents. For example, the device can comprise a sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm. The device can also comprise an anti-thrombogenic coating distributed over at least a portion of the device such that the pores are substantially free of webs formed by the coating.
Abstract translation: 提供涂布方法和相关设备。 这样的装置可以包括支架。 例如,该装置可以包括侧壁和侧壁中的多个孔,其尺寸被设计成当管状构件定位时防止血液通过侧壁流入动脉瘤至足以导致动脉瘤血栓形成和愈合的程度 在血管中并且与动脉瘤相邻。 该装置还可以包含分布在装置的至少一部分上的抗血栓形成的涂层,使得孔基本上不含由涂层形成的网。
-
公开(公告)号:US20200323664A1
公开(公告)日:2020-10-15
申请号:US16913871
申请日:2020-06-26
Applicant: Covidien LP
Inventor: John Wainwright , Todd Mendelson , Kurt Haggstrom , Masoud Molaei , Victoria Schuman , Min-Shyan Sheu
Abstract: Medical devices that include a tubular member with a plurality of braided filaments, each filament crossing another of the filaments at a respective crossing point forming sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, the pores have an average pore size that is less than or equal to about 500 microns when the tubular member is in an expanded state, the filaments possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device with pores substantially free of webs formed by antithrombogenic material, such that fewer than 5% of the crossing points have webs formed by antithrombogenic material thereby permitting the pores to be substantially free of webs.
-
公开(公告)号:US20170119557A1
公开(公告)日:2017-05-04
申请号:US15404760
申请日:2017-01-12
Applicant: Covidien LP
Inventor: John Wainwright , Todd Mendelson , Kurt Haggstrom , Masoud Molaei , Victoria Schuman , Min-shyan Sheu
CPC classification number: A61F2/90 , A61F2/07 , A61F2/966 , A61F2002/072 , A61F2002/823 , A61F2002/9665 , A61F2210/0076 , A61F2230/0069 , A61F2250/0023 , A61F2250/0067 , A61F2310/00389 , B05D1/18 , B05D3/0272 , B05D3/04
Abstract: Medical devices that include a tubular member with a plurality of braided filaments, each filament crossing another of the filaments at a respective crossing point forming sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, the pores have an average pore size that is less than or equal to about 500 microns when the tubular member is in an expanded state, the filaments possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device with pores substantially free of webs formed by antithrombogenic material, such that fewer than 5% of the crossing points have webs formed by antithrombogenic material thereby permitting the pores to be substantially free of webs.
-
公开(公告)号:US10226366B2
公开(公告)日:2019-03-12
申请号:US15404760
申请日:2017-01-12
Applicant: Covidien LP
Inventor: John Wainwright , Todd Mendelson , Kurt Haggstrom , Masoud Molaei , Victoria Schuman , Min-Shyan Sheu
Abstract: Medical devices that include a tubular member with a plurality of braided filaments, each filament crossing another of the filaments at a respective crossing point forming sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, the pores have an average pore size that is less than or equal to about 500 microns when the tubular member is in an expanded state, the filaments possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device with pores substantially free of webs formed by antithrombogenic material, such that fewer than 5% of the crossing points have webs formed by antithrombogenic material thereby permitting the pores to be substantially free of webs.
-
5.
公开(公告)号:US09545301B2
公开(公告)日:2017-01-17
申请号:US14317587
申请日:2014-06-27
Applicant: Covidien LP
Inventor: John Wainwright , Todd Mendelson , Kurt Haggstrom , Masoud Molaei , Victoria Schuman , Min-Shyan Sheu
CPC classification number: A61F2/90 , A61F2/07 , A61F2/966 , A61F2002/072 , A61F2002/823 , A61F2002/9665 , A61F2210/0076 , A61F2230/0069 , A61F2250/0023 , A61F2250/0067 , A61F2310/00389 , B05D1/18 , B05D3/0272 , B05D3/04
Abstract: Coating methods and related devices are provided. Such devices can include stents. For example, the device can comprise a sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm. The device can also comprise an anti-thrombogenic coating distributed over at least a portion of the device such that the pores are substantially free of webs formed by the coating.
Abstract translation: 提供涂布方法和相关设备。 这样的装置可以包括支架。 例如,该装置可以包括侧壁和侧壁中的多个孔,其尺寸被设计成当管状构件定位时防止血液通过侧壁流入动脉瘤至足以导致动脉瘤血栓形成和愈合的程度 在血管中并且与动脉瘤相邻。 该装置还可以包含分布在装置的至少一部分上的抗血栓形成的涂层,使得孔基本上不含由涂层形成的网。
-
6.
公开(公告)号:US20140277400A1
公开(公告)日:2014-09-18
申请号:US13844577
申请日:2013-03-15
Applicant: COVIDIEN LP
Inventor: John Wainwright , Todd Mendelson , Kurt Haggstrom , Xiaodong Ma , Masoud Molaei , John Muri , Anastasia Righter , Victoria Schuman , Min-Shyan Sheu
IPC: A61F2/07
CPC classification number: A61F2/07 , A61F2/90 , A61F2002/072 , A61F2002/823 , A61F2250/0067
Abstract: Coating methods and related devices are provided. Such devices can include stents. For example, the device can comprise a sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm. The device can also comprise an anti-thrombogenic coating distributed over at least a portion of the device such that the pores are substantially free of webs formed by the coating.
Abstract translation: 提供涂布方法和相关设备。 这样的装置可以包括支架。 例如,该装置可以包括侧壁和侧壁中的多个孔,其尺寸被设计成当管状构件定位时防止血液通过侧壁流入动脉瘤至足以导致动脉瘤血栓形成和愈合的程度 在血管中并且与动脉瘤相邻。 该装置还可以包含分布在装置的至少一部分上的抗血栓形成的涂层,使得孔基本上不含由涂层形成的网。
-
公开(公告)号:US11376141B2
公开(公告)日:2022-07-05
申请号:US16913871
申请日:2020-06-26
Applicant: Covidien LP
Inventor: John Wainwright , Todd Mendelson , Kurt Haggstrom , Masoud Molaei , Victoria Schuman , Min-Shyan Sheu
Abstract: Medical devices that include a tubular member with a plurality of braided filaments, each filament crossing another of the filaments at a respective crossing point forming sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, the pores have an average pore size that is less than or equal to about 500 microns when the tubular member is in an expanded state, the filaments possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device with pores substantially free of webs formed by antithrombogenic material, such that fewer than 5% of the crossing points have webs formed by antithrombogenic material thereby permitting the pores to be substantially free of webs.
-
公开(公告)号:US10695200B2
公开(公告)日:2020-06-30
申请号:US16277170
申请日:2019-02-15
Applicant: Covidien LP
Inventor: John Wainwright , Todd Mendelson , Kurt Haggstrom , Masoud Molaei , Victoria Schuman , Min-Shyan Sheu
Abstract: Medical devices that include a tubular member with a plurality of braided filaments, each filament crossing another of the filaments at a respective crossing point forming sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, the pores have an average pore size that is less than or equal to about 500 microns when the tubular member is in an expanded state, the filaments possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device with pores substantially free of webs formed by antithrombogenic material, such that fewer than 5% of the crossing points have webs formed by antithrombogenic material thereby permitting the pores to be substantially free of webs.
-
公开(公告)号:US20190175373A1
公开(公告)日:2019-06-13
申请号:US16277170
申请日:2019-02-15
Applicant: Covidien LP
Inventor: John Wainwright , Todd Mendelson , Kurt Haggstrom , Masoud Molaei , Victoria Schuman , Min-Shyan Sheu
CPC classification number: A61F2/90 , A61F2/07 , A61F2/966 , A61F2002/072 , A61F2002/823 , A61F2002/9665 , A61F2210/0076 , A61F2230/0069 , A61F2250/0023 , A61F2250/0067 , A61F2310/00389 , B05D1/18 , B05D3/0272 , B05D3/04
Abstract: Medical devices that include a tubular member with a plurality of braided filaments, each filament crossing another of the filaments at a respective crossing point forming sidewall and a plurality of pores in the sidewall that are sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the tubular member is positioned in a blood vessel and adjacent to the aneurysm, the pores have an average pore size that is less than or equal to about 500 microns when the tubular member is in an expanded state, the filaments possessing antithrombogenic surfaces to increase antithrombogenicity of the medical device with pores substantially free of webs formed by antithrombogenic material, such that fewer than 5% of the crossing points have webs formed by antithrombogenic material thereby permitting the pores to be substantially free of webs.
-
-
-
-
-
-
-
-